214 related articles for article (PubMed ID: 37322549)
21. NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression.
Long Y; Ren Y; Wei Q; Mobet Y; Liu Y; Zhao H; Liu T; Cheng L; Yi P
Int J Med Sci; 2023; 20(8):1079-1090. PubMed ID: 37484809
[TBL] [Abstract][Full Text] [Related]
22. Early recruitment of PARP-dependent m
Legartová S; Svobodová Kovaříková A; Běhalová Suchánková J; Polášek-Sedláčková H; Bártová E
RNA Biol; 2022 Jan; 19(1):1153-1171. PubMed ID: 36382943
[TBL] [Abstract][Full Text] [Related]
23. N-acetyltransferase 10 promotes the progression of oral squamous cell carcinoma through N4-acetylcytidine RNA acetylation of MMP1 mRNA.
Liu Y; Huang H; Zhang CB; Fan HN
Cancer Sci; 2023 Nov; 114(11):4202-4215. PubMed ID: 37705232
[TBL] [Abstract][Full Text] [Related]
24. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation.
Shi J; Yang C; Zhang J; Zhao K; Li P; Kong C; Wu X; Sun H; Zheng R; Sun W; Chen L; Kong X
Circ Res; 2023 Dec; 133(12):989-1002. PubMed ID: 37955115
[TBL] [Abstract][Full Text] [Related]
25. N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9.
Ding M; Yu Z; Lu T; Hu S; Zhou X; Wang X
Clin Transl Med; 2024 Jul; 14(7):e1747. PubMed ID: 38961519
[TBL] [Abstract][Full Text] [Related]
26. ac4C acetylation of RUNX2 catalyzed by NAT10 spurs osteogenesis of BMSCs and prevents ovariectomy-induced bone loss.
Yang W; Li HY; Wu YF; Mi RJ; Liu WZ; Shen X; Lu YX; Jiang YH; Ma MJ; Shen HY
Mol Ther Nucleic Acids; 2021 Dec; 26():135-147. PubMed ID: 34513300
[No Abstract] [Full Text] [Related]
27. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine.
Arango D; Sturgill D; Yang R; Kanai T; Bauer P; Roy J; Wang Z; Hosogane M; Schiffers S; Oberdoerffer S
Mol Cell; 2022 Aug; 82(15):2797-2814.e11. PubMed ID: 35679869
[TBL] [Abstract][Full Text] [Related]
28. NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease.
Achour C; Oberdoerffer S
Curr Opin Genet Dev; 2024 May; 87():102207. PubMed ID: 38820741
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of NAT10 as ac4C writer in diseases.
Xie L; Zhong X; Cao W; Liu J; Zu X; Chen L
Mol Ther Nucleic Acids; 2023 Jun; 32():359-368. PubMed ID: 37128278
[TBL] [Abstract][Full Text] [Related]
30. NAT10 accelerates pulmonary fibrosis through N4-acetylated TGFB1-initiated epithelial-to-mesenchymal transition upon ambient fine particulate matter exposure.
Shenshen Wu ; Yin L; Han K; Jiang B; Meng Q; Aschner M; Li X; Chen R
Environ Pollut; 2023 Apr; 322():121149. PubMed ID: 36731737
[TBL] [Abstract][Full Text] [Related]
31. Profile analysis of N4-acetylcytidine (ac4C) on mRNA of human lung adenocarcinoma and paired adjacent non-tumor tissues.
Shang X; Peng Y; Wang Y; Feng Z; Li M; Peng Z; Ren W
Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130498. PubMed ID: 37890598
[TBL] [Abstract][Full Text] [Related]
32. A Chemical Signature for Cytidine Acetylation in RNA.
Thomas JM; Briney CA; Nance KD; Lopez JE; Thorpe AL; Fox SD; Bortolin-Cavaille ML; Sas-Chen A; Arango D; Oberdoerffer S; Cavaille J; Andresson T; Meier JL
J Am Chem Soc; 2018 Oct; 140(40):12667-12670. PubMed ID: 30252461
[TBL] [Abstract][Full Text] [Related]
33. Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma.
Pan Z; Bao Y; Hu M; Zhu Y; Tan C; Fan L; Yu H; Wang A; Cui J; Sun G
Cell Death Discov; 2023 Feb; 9(1):56. PubMed ID: 36765042
[TBL] [Abstract][Full Text] [Related]
34. N4-acetylcytidine regulates the replication and pathogenicity of enterovirus 71.
Hao H; Liu W; Miao Y; Ma L; Yu B; Liu L; Yang C; Zhang K; Chen Z; Yang J; Zheng Z; Zhang B; Deng F; Gong P; Yuan J; Hu Z; Guan W
Nucleic Acids Res; 2022 Sep; 50(16):9339-9354. PubMed ID: 35971620
[TBL] [Abstract][Full Text] [Related]
35. N4-acetylcytidine modifies primary microRNAs for processing in cancer cells.
Zhang H; Lu R; Huang J; Li L; Cao Y; Huang C; Chen R; Wang Y; Huang J; Zhao X; Yu J
Cell Mol Life Sci; 2024 Feb; 81(1):73. PubMed ID: 38308713
[TBL] [Abstract][Full Text] [Related]
36. Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation.
Shrimp JH; Jing Y; Gamage ST; Nelson KM; Han J; Bryson KM; Montgomery DC; Thomas JM; Nance KD; Sharma S; Fox SD; Andressen T; Sinclair WR; Wu H; Allali-Hassani A; Senisterra G; Vedadi M; Lafontaine D; Dahlin JL; Marmorstein R; Walters MA; Meier JL
ACS Med Chem Lett; 2021 Jun; 12(6):887-892. PubMed ID: 34141066
[TBL] [Abstract][Full Text] [Related]
37. PACES: prediction of N4-acetylcytidine (ac4C) modification sites in mRNA.
Zhao W; Zhou Y; Cui Q; Zhou Y
Sci Rep; 2019 Jul; 9(1):11112. PubMed ID: 31366994
[TBL] [Abstract][Full Text] [Related]
38. Enhanced ac4C detection in RNA via chemical reduction and cDNA synthesis with modified dNTPs.
Relier S; Schiffers S; Beiki H; Oberdoerffer S
RNA; 2024 Jun; 30(7):938-953. PubMed ID: 38697668
[TBL] [Abstract][Full Text] [Related]
39. Protocol for base resolution mapping of ac4C using RedaC:T-seq.
Sturgill D; Arango D; Oberdoerffer S
STAR Protoc; 2022 Dec; 3(4):101858. PubMed ID: 36595942
[TBL] [Abstract][Full Text] [Related]
40. NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer.
Xie R; Cheng L; Huang M; Huang L; Chen Z; Zhang Q; Li H; Lu J; Wang H; Zhou Q; Huang J; Chen X; Lin T
Cancer Res; 2023 May; 83(10):1666-1683. PubMed ID: 36939377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
